$SLQT

SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook

SelectQuote (SLQT) shares fell 14.69% in pre-market trading after reporting Q4 fiscal 2026 revenue of $321.7M, missing estimates, and issuing a fiscal 2027 revenue outlook of $1.35B-$1.45B, below consensus. The company reported a net loss of $16.8M, though adjusted EBITDA improved. CEO Tim Danker highlighted success in the Senior Medicare Advantage segment.

Original reporting
Published Aug 25, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 3:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook — source image
Decision brief

The 30-second read

$SLQTBearishHigh
01

Why it matters

The earnings miss and lowered guidance triggered a 14.7% pre‑market decline, indicating negative market reaction.

02

Market read

The news is material for traders focused on healthcare distribution stocks and small‑cap earnings volatility.

03

What to watch

Strong Medicare Advantage policy growth and full‑year revenue increase could support a rebound later in the year.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

SelectQuote, a provider of insurance distribution and healthcare services, released its Q4 2026 earnings and FY2027 outlook.

Company-level read

Ticker impact

$SLQTBearishHigh confidence
Context

SelectQuote reported Q4 loss, revenue miss and lowered FY2027 revenue guidance, causing a 14.7% pre‑market drop.

Expected impact

downward pressure over the next few trading sessions

Evidence & confidence

Guidance $1.35‑$1.45B vs $1.65B consensus and a loss per share beat expectations, triggering a sharp sell‑off.

Market effects

Insurance distribution and healthcare services sector may see broader pressure as peers face similar revenue guidance challenges.

U.S. small‑cap healthcare distribution stocks could experience modest sell‑offs.

Limited to U.S. markets; no immediate global ripple.

Counterpoint

If the company can sustain EBITDA growth and cash flow, the price dip may present a buying opportunity.

Key entities

  • SelectQuote, Inc.

    Insurance distribution and healthcare services firm.

Related articles

$SLQTHighAI 8/10

SelectQuote (SLQT) Q4 2026 Earnings Call Transcript

SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.

$SLQTMedAI 8/10

SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line

SelectQuote (SLQT) reported fiscal 2026 revenue of $1.62B, up 6% YoY, with operating cash flow increasing $44M. However, it posted a Q4 net loss of $16.8M and guided fiscal 2027 revenue lower. Healthcare Services revenue grew 14% to $845M, despite drug pricing changes. The company identified $30M in annual savings from AI tools. Guidance expects fiscal 2027 revenue to decline 14% at the midpoint, with Medicare Advantage policies projected to fall further.

$SLQTMedAI 8/10

SelectQuote Q4 Earnings Call Highlights

SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$SLQTHigh

SelectQuote, Inc. (SLQT): Results of Operations and Financial Condition

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results Fourth Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $321.7 million • Net loss of $(16.8) million • Adjusted EBITDA* of $11.9 million Fiscal Year 2027 Guidance Ranges:

$CRWDMedAI 8/10

Jim Cramer Highlights CrowdStrike (CRWD) as AI Security Concerns Lift Cybersecurity Stocks

CrowdStrike (CRWD) rose 14% after Jim Cramer highlighted its AI-driven cybersecurity opportunities. Q2 revenue grew 26% to $1.47B, with ARR up 25% to $5.84B. The company raised its full-year net new ARR growth outlook to 34%. CEO George Kurtz emphasized AI threats and CrowdStrike's solutions. The stock's high valuation (forward P/E 188.7x) leaves little room for growth slowdowns.